Housseman; Christopher Gaetan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Housseman; Christopher Gaetan.The latest application filed is for "modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use".

Company Profile

0.11.15

Housseman; Christopher Gaetan - Montreuil FR
HOUSSEMAN; Christopher Gaetan - Romainville FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20210238159 - Altenbach; Robert J. ; et al.	2021-08-05
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,988,454 - Altenbach , et al. April 27, 2	2021-04-27
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,981,890 - Altenbach , et al. April 20, 2	2021-04-20
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,844,042 - Altenbach , et al. November 24, 2	2020-11-24
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,844,041 - Altenbach , et al. November 24, 2	2020-11-24
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,829,473 - Altenbach , et al. November 10, 2	2020-11-10
Modulators Of The Cystic Fibrosis Transmembrane Conductance Regulator Protein And Methods Of Use App 20200277275 - Altenbach; Robert J. ; et al.	2020-09-03
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277276 - Altenbach; Robert J. ; et al.	2020-09-03
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277273 - Altenbach; Robert J. ; et al.	2020-09-03
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277274 - Altenbach; Robert J. ; et al.	2020-09-03
N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 10,647,717 - Akkari , et al.	2020-05-12
N-Sulfonylated-Pyrazolo[3,4-b]Pyridin-6-Carboxamides and Method of Use App 20190330207 - Akkari; Rhalid ; et al.	2019-10-31
N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20190202823 - Akkari; Rhalid ; et al.	2019-07-04
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 10,259,810 - Akkari , et al.	2019-04-16
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20190077784 - Altenbach; Robert J. ; et al.	2019-03-14
Substituted pyrrolidines and methods of use Grant 9,981,910 - Altenbach , et al. May 29, 2	2018-05-29
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders App 20180127425 - DESROY; Nicolas ; et al.	2018-05-10
N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20180105522 - Akkari; Rhalid ; et al.	2018-04-19
Substituted Pyrrolidines and Methods of Use App 20180099931 - Altenbach; Robert J. ; et al.	2018-04-12
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 9,890,158 - Akkari , et al. February 13, 2	2018-02-13
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Grant 9,796,719 - Desroy , et al. October 24, 2	2017-10-24
Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of use Grant 9,796,711 - Akkari , et al. October 24, 2	2017-10-24
Novel Compounds For Treatment Of Cystic Fibrosis App 20170100386 - Akkari; Rhalid ; et al.	2017-04-13
SUBSTITUTED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXYLIC ACIDS AND METHOD OF USE App 20170101406 - Akkari; Rhalid ; et al.	2017-04-13
N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20170101405 - Akkari; Rhalid ; et al.	2017-04-13
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders App 20160214986 - DESROY; Nicolas ; et al.	2016-07-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.